Literature DB >> 11809615

The thrifty phenotype hypothesis.

C N Hales1, D J Barker.   

Abstract

The thrifty phenotype hypothesis proposes that the epidemiological associations between poor fetal and infant growth and the subsequent development of type 2 diabetes and the metabolic syndrome result from the effects of poor nutrition in early life, which produces permanent changes in glucose-insulin metabolism. These changes include reduced capacity for insulin secretion and insulin resistance which, combined with effects of obesity, ageing and physical inactivity, are the most important factors in determining type 2 diabetes. Since the hypothesis was proposed, many studies world-wide have confirmed the initial epidemiological evidence, although the strength of the relationships has varied from one study to another. The relationship with insulin resistance is clear at all ages studied. Less clear is the relationship with insulin secretion. The relative contribution of genes and environment to these relationships remains a matter of debate. The contributions of maternal hyperglycaemia and the trajectory of postnatal growth need to be clarified.

Entities:  

Mesh:

Year:  2001        PMID: 11809615     DOI: 10.1093/bmb/60.1.5

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  673 in total

1.  The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction.

Authors:  Y Diz-Chaves; L Toba; J Fandiño; L C González-Matías; L M Garcia-Segura; F Mallo
Journal:  J Neuroinflammation       Date:  2018-12-05       Impact factor: 8.322

2.  Intervention, integration and translation in obesity research: Genetic, developmental and metaorganismal approaches.

Authors:  Maureen A O'Malley; Karola Stotz
Journal:  Philos Ethics Humanit Med       Date:  2011-01-28       Impact factor: 2.464

3.  Long-term effects of culture of preimplantation mouse embryos on behavior.

Authors:  David J Ecker; Paula Stein; Zhe Xu; Carmen J Williams; Gregory S Kopf; Warren B Bilker; Ted Abel; Richard M Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-27       Impact factor: 11.205

Review 4.  Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals?

Authors:  James A Armitage; Imran Y Khan; Paul D Taylor; Peter W Nathanielsz; Lucilla Poston
Journal:  J Physiol       Date:  2004-09-30       Impact factor: 5.182

Review 5.  Epigenetics and the environment: emerging patterns and implications.

Authors:  Robert Feil; Mario F Fraga
Journal:  Nat Rev Genet       Date:  2012-01-04       Impact factor: 53.242

Review 6.  Epigenetic mechanisms in developmental programming of adult disease.

Authors:  Man Chen; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-16       Impact factor: 7.851

Review 7.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

8.  Large-for-Gestational-Age May Be Associated With Lower Fetal Insulin Sensitivity and β-Cell Function Linked to Leptin.

Authors:  Yu Dong; Zhong-Cheng Luo; Anne Monique Nuyt; Francois Audibert; Shu-Qin Wei; Haim A Abenhaim; Emmanuel Bujold; Pierre Julien; Hong Huang; Emile Levy; William D Fraser
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

9.  Early-life immune activation increases song complexity and alters phenotypic associations between sexual ornaments.

Authors:  Loren Merrill; Madeleine F Naylor; Merria Dalimonte; Sean McLaughlin; Tara E Stewart; Jennifer L Grindstaff
Journal:  Funct Ecol       Date:  2017-06-29       Impact factor: 5.608

Review 10.  Epigenetics and chromatin dynamics: a review and a paradigm for functional disorders.

Authors:  T Ordog; S A Syed; Y Hayashi; D T Asuzu
Journal:  Neurogastroenterol Motil       Date:  2012-10-24       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.